Institute events
RSS feedThe neurospecific expression of SMN is necessary but not sufficient for the survival of SMA mice – Interview with M.G. Biferi & A. Besse
Interview with Maria-Grazia Biferi, Head of the BOND team (Motor-neurone disease [ALS & SMA] biotherapies team) and Aurore Besse, Preclinical Project Manager at the Institute of Myology. What are the origins of the project? This project started as a doctoral thesis by Aurore Besse and, with great teamwork, resulted in publication last May in Molecular … [Read more]
COVID-19, consultations and clinical trials: 6 questions for Dominique DuchĂȘne
Dominique DuchĂȘne, Project Manager, Clinical Research Associate (CRA) Manager at I-Motion, the paediatric clinical trial platform.âšâš If I could ask you who you are and what your mission is, and how long you have been working at the Institute? I joined the Institute of Myology in 2011 and I am currently Project Manager at I-Motion. … [Read more]
COVID-19 and the organisation of the neuromyology consultation – 5 questions for Isabelle Coupa
Interview with Isabelle Coupa, Nursing Manager at the Institute of Myologyâs Service of Neuro-Myology. If I could ask you who you are and what your mission is? I am Isabelle Coupa, Nursing Manager at the Institute of Myologyâs Service of Neuro-Myology. I hold a University Degree in Nursing and I have worked for a number … [Read more]
Release of the 79th newsletter from the Institute
The Institute of Myology teams fully mobilised! Welcome to our 79th newsletter. After these last weeks of confinement, Dr. Vincent Varlet, Secretary General of the Institute of Myology, and Pr. Bertrand Fontaine, Medical and Scientific Director of the Institute of Myology, Head of the service of Neuro-Myology and Director of the Myology Centre … [Read more]
Efgartigimod in Myasthenia gravis : the ADAPT phase III trial would have met its primary efficacy endpoint
An immunomodulatory biotherapy, efgartigimod is a fragment of antibodies directed against the neonatal Fc or FcRn receptors. These receptors prevent the breakdown of immunoglobulins G (IgG), which include the autoantibodies produced in myasthenia gravis. By binding to FcRn, efgartigimod (or ARGX-113) reduces the recycling of IgG and therefore their circulating rate. Administered as an infusion … [Read more]
COVID-19 and clinical trials in adults â 6 questions for KubĂ©raka Mariampillai
Interview with KubĂ©raka Mariampillai, Project Manager for the Adult Clinical Trials platform at the Institute of Myology, headed by Prof. Bertrand Fontaine and coordinated by Dr Giorgia Querin, and member of “Inflammatory Myopathies and Innovative Targeted Therapies” team 8 at the Research Centre, headed by Prof. Olivier Benveniste. If you could tell me who you … [Read more]
COVID-19 and psychological counselling : 5 questions for Prof. Marcela Gargiulo
Interview with Prof. Marcela Gargiulo, psychologist and leader of the team of psychologists at the Service of Neuro-Myology, headed by Prof. Bertrand Fontaine. If I could ask you who you are and what your mission is? I am a clinical psychologist and I have been working at the Institute of Myology since it was created … [Read more]
The Institute of Myology is recruiting a Helpdesk Assistant (M/F)
Located in Paris at the heart of the largest European hospital, PitiĂ©-SalpĂȘtriĂšre, the Institute of Myology was created in 1996 by AFM-Telethon, a patientâs organization. The Institute of Myology coordinates, around the patient, medical care, basic research, applied research, clinical research and teaching. The main objective of the post is to promote and provide helpdesk … [Read more]
Study of grip strength in patients with DMD – Interview with J.-Y. Hogrel
The team at the Neuromuscular Physiology and Evaluation Laboratory of the Institute of Myology participated with, in particular, clinicians from I-Motion, in a study intended to assess grip strength in patients with Duchenne Muscular Dystrophy. The results were published in March 2020, in the Journal of Neurology*. Interview with Jean-Yves Hogrel, Head of the Laboratory. … [Read more]
COVID-19 and clinical research: 4 questions for Prof. Olivier Benveniste
Interview with Prof. Olivier Benveniste, Director of research Team 8, “Inflammatory myopathies and innovative targeted therapies“, at the Institute’s Centre for Myology Research, University Professor â Hospital Practitioner at the Department of Internal Medicine and Clinical Immunology (the DMIIC) at the PitiĂ©-SalpĂȘtriĂšre Hospital, Coordinator for the French National Myositis Network. If you could provide some … [Read more]